Sample Chain of Custody Log for HCT/Ps: Practice Guide

A complete sample chain of custody log for human cellular tissue products establishes bidirectional traceability by linking donor lot numbers, distributor cold-chain receipt data, and freezer monitoring logs directly to the patient chart. Maintaining these standardized records across your biologics inventory eliminates documentation gaps during tissue recalls, temperature excursions, and federal compliance audits. Review the field-by-field framework below to implement an audit-ready custody protocol in your clinical workflow.

Why Practice Managers Need a Standardized HCT/P Log

Clinics offering regenerative medicine services often manage a diverse inventory of biologics, including Wharton's Jelly, amniotic allografts, cord blood, and MSC exosomes. Unlike standard pharmaceutical supplies, human cellular and tissue-based products require bidirectional traceability. The practice must be able to trace a specific donor lot forward to the exact patient who received it, and trace a patient's treatment backward to the originating tissue bank and donor identification number.

Without a unified intake and disposition log, practices face three primary operational risks:

• Financial loss from cold-chain failures: Cryopreserved tissues shipped on dry ice or vapor-phase liquid nitrogen degrade rapidly if intake procedures are delayed or improperly documented. If a shipment arrives compromised, the distributor or tissue bank will require immediate, timestamped receiving documentation to process a replacement.
• Audit vulnerabilities: Healthcare accrediting bodies and state medical boards routinely inspect tissue logs during site visits. Missing lot numbers, unrecorded freezer transfers, or incomplete waste disposal records can result in citations.
• EHR fragmentation: Relying solely on clinical notes inside an Electronic Health Record (EHR) often leaves gaps in the pre-clinical supply chain. While the EHR tracks what was administered to the patient, a master facility log tracks the tissue while it sits in inventory, capturing items that may eventually expire or be discarded without ever reaching a patient chart.

Sample Chain of Custody Log for Human Cellular Tissue Products

Practice administrators can adapt the following structural template into a bound physical logbook, a secure spreadsheet, or a custom module within their practice management software. Each row or entry sheet should represent a single vial or unit of tissue, broken down into four chronological phases.

Phase 1: Shipment Receipt and Verification

• Date and Time of Delivery: Exact timestamp when the courier hands off the package.
• Receiving Staff Name and Initials: The designated team member who opened and inspected the box.
• Source Facility / Distributor Name: The tissue bank and the supplying distributor.
• Product Description and Volume: Specific biologic type (e.g., amniotic membrane allograft, 1 mL vial).
• Unique Tissue ID / Lot Number / Serial Number: The distinct alphanumeric code assigned by the processing tissue bank (often accompanied by a peel-off barcode sticker).
• Expiration Date: As printed on the inner vial label.
• Shipping Condition Inspection: Packaging integrity (Intact / Damaged) and coolant status (Dry ice present / Ice packs frozen / Ambient temperature verified).
• Acceptance Status: Accepted into inventory or Quarantined/Rejected (if rejected, note the Return Merchandise Authorization number).

Phase 2: Storage and Environmental Monitoring

• Assigned Storage Location: Specific refrigerator, -20°C freezer, -80°C ultra-low freezer, or LN2 dewar identifier.
• Temperature at Transfer: Reading on the storage unit's calibrated thermometer at the moment the tissue is placed inside.
• Daily Temperature Log Cross-Reference: Confirmation that the storage unit is monitored by a continuous digital data logger or manual twice-daily log.

Phase 3: Clinical Preparation and Administration

• Date and Time Removed from Storage: Timestamp initiating the thaw or reconstitution window.
• Preparing Clinician / Staff Initials: The medical assistant, nurse, or physician preparing the product.
• Reconstitution Details (if applicable): Diluent used, lot number of the diluent, and expiration date of the diluent.
• Patient Identifier: Patient's full name, date of birth, and internal Medical Record Number (MRN).
• Treating Physician Name: The licensed provider performing the procedure.
• Anatomical Site of Administration: Specific joint, tissue plane, or aesthetic zone treated.
• Tissue Bank Return Card Status: Confirmation that the manufacturer's graft tracking record was completed and returned to the source facility.

Phase 4: Wastage and Final Disposition (If Not Administered)

• Disposition Type: Expired, Dropped/Compromised, Thawed Not Used, or Recalled.
• Date and Time of Disposal: When the unit was permanently removed from usable inventory.
• Method of Destruction: Biohazard medical waste incineration or return to manufacturer.
• Witness Signature: Second staff member verifying the destruction of high-value biologic inventory to prevent diversion or accounting errors.

Operational Workflow Checklist: From Receiving Dock to Procedure Room

A log is only as reliable as the staff members filling it out. Practice managers should pair their tracking log with a Standard Operating Procedure (SOP) that governs daily clinic operations:

• Centralize receiving authority: Designate one primary and one backup staff member to unbox biologic shipments immediately upon arrival. Instruct front desk staff never to leave dry-ice packages in a general mailroom.
• Utilize peel-and-stick labels: Most AATB-accredited tissue banks provide multiple peel-off barcode stickers on the outer packaging or vial wrapper. Place one sticker on the master facility chain of custody log, one on the tissue bank's return postcard (or enter via their online portal), and scan one into the patient's EHR chart.
• Separate clinical and research/educational inventory: If the practice holds demonstration vials or non-clinical samples, store them in a completely separate physical container from patient-use products.
• Audit physical inventory against the log monthly: Reconcile the physical vials inside the freezer against the open lines on the chain of custody log once a month. This prevents surprise stockouts on procedure days and flags nearing expiration dates early.
• Standardize ancillaries: Ensure the procedure room is stocked with the appropriate medical supplies required for sterile draw and administration, logging the lot numbers of any sterile saline or mixing components alongside the biologic record.

For the Treating Physician: Clinical Relevance of Traceability

While practice managers generally oversee inventory logistics, the treating physician carries the ultimate clinical responsibility for what is introduced into a patient. Whether operating within orthopedics, pain management, or aesthetics, clinicians benefit directly from meticulous chain of custody documentation.

First, biological activity and cellular or protein viability are directly tied to cold-chain adherence. If a cryopreserved product experiences an unrecorded thaw-refreeze cycle due to sloppy receiving protocols, the clinical outcome may be compromised, leading the physician to misinterpret a handling failure as a treatment non-response. Second, when integrating biologics into multi-modal protocols alongside regenerative devices like extracorporeal shockwave therapy (ECSWT) or high-power laser therapy, maintaining precise lot-level records allows the physician to correlate specific product batches with patient recovery timelines and clinical tolerability.

Evaluating Distributors on Compliance Support

Your clinic's internal chain of custody starts where your distributor's chain of custody ends. When evaluating vendors for regenerative products, practice administrators should examine how the supplier supports compliance at the point of handoff.

A qualified medical distributor should provide transparent sourcing documentation, verified cold-chain shipping containers engineered to outlast standard courier delays, and clear packing slips that match the lot numbers inside the box. Working with an established, licensed distributor streamlines your intake workflow by ensuring that every shipment arrives with complete, legible regulatory paperwork ready for your facility's master log.

What This Means for Your Practice

To tighten your clinic's biologic compliance and inventory management this week, take these concrete next steps:

1. Audit your current log: Compare your existing tracking sheet against the four-phase template above. If you are not currently recording shipping container conditions upon arrival or witness signatures for wasted vials, add those columns immediately.
2. Walk the receiving path: Trace the physical journey a biologic shipment takes from the courier's hands to your freezer. Eliminate any bottlenecks where a package might sit at room temperature unlogged.
3. Verify vendor credentials: Confirm that your biologic suppliers maintain proper state licensure and provide complete lot-level documentation with every order.

If you are setting up a new regenerative service line or refining your existing procurement protocols, contact our team at Dallas Regenerative Solutions to discuss compliant biologic sourcing, cold-chain logistics, and practice integration support.